VPIM
TERN

Vanguard Personalized Indexing Management’s Terns Pharmaceuticals TERN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Buy
22,676
+4,121
+22% +$169K 0.01% 840
2025
Q4 		$750K Buy
18,555
+906
+5% +$20.9K 0.01% 1051
2025
Q3 		$133K Buy
17,649
+1,038
+6% +$6.63K ﹤0.01% 1775
2025
Q2 		$62K Buy
16,611
+373
+2% +$1.17K ﹤0.01% 1798
2025
Q1 		$44.8K Buy
+16,238
New +$66.3K ﹤0.01% 1687

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Personalized Indexing Management's TERN Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Terns Pharmaceuticals (TERN) stake by 22% in Q1 2026, buying an estimated $169K and bringing the position to 22,676 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #840.

Vanguard Personalized Indexing Management first reported a position in TERN in Q1 2025 and has held it in 5 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Vanguard Personalized Indexing Management held 22,676 shares of Terns Pharmaceuticals worth $1.2M as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 4,121 Terns Pharmaceuticals shares in Q1 2026, an estimated $169K.
  • Terns Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #840 holding.
  • Vanguard Personalized Indexing Management first reported a position in Terns Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.